BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38373525)

  • 1. Tannic acid and zinc ion coordination of nanase for the treatment of inflammatory bowel disease by promoting mucosal repair and removing reactive oxygen and nitrogen species.
    Zhang C; Li Q; Xing J; Yang Y; Zhu M; Lin L; Yu Y; Cai X; Wang X
    Acta Biomater; 2024 Mar; 177():347-360. PubMed ID: 38373525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional two-dimensional Bi
    Zhang C; Li Q; Shan J; Xing J; Liu X; Ma Y; Qian H; Chen X; Wang X; Wu LM; Yu Y
    Acta Biomater; 2023 Apr; 160():252-264. PubMed ID: 36805534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. W-GA nanodots restore intestinal barrier functions by regulating flora disturbance and relieving excessive oxidative stress to alleviate colitis.
    Li Q; Zhang C; Zhu M; Shan J; Qian H; Ma Y; Wang X
    Acta Biomater; 2024 Jul; 182():260-274. PubMed ID: 38777175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasmall Cu
    Li S; Chen Z; Wang M; Yang F; Zhang S; Qiao C; Chu W; Yue W
    ACS Appl Mater Interfaces; 2024 Jan; 16(3):3116-3125. PubMed ID: 38224533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrathin Hafnium Disulfide Atomic Crystals with ROS-Scavenging and Colon-Targeting Capabilities for Inflammatory Bowel Disease Treatment.
    Li R; Fan Y; Liu L; Ma H; Gong D; Miao Z; Wang H; Zha Z
    ACS Nano; 2022 Sep; 16(9):15026-15041. PubMed ID: 36037406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The progression of inorganic nanoparticles and natural products for inflammatory bowel disease.
    Li Q; Lin L; Zhang C; Zhang H; Ma Y; Qian H; Chen XL; Wang X
    J Nanobiotechnology; 2024 Jan; 22(1):17. PubMed ID: 38172992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice.
    Zhu S; Jiang X; Boudreau MD; Feng G; Miao Y; Dong S; Wu H; Zeng M; Yin JJ
    J Nanobiotechnology; 2018 Nov; 16(1):86. PubMed ID: 30384844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease.
    Bao M; Wang K; Li J; Li Y; Zhu H; Lu M; Zhang Y; Fan Q; Han L; Wang K; Wang D; Gao Y; Peng B; Ming Z; Liu W
    Acta Biomater; 2023 Apr; 161():250-264. PubMed ID: 36863680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oral polyphenol host-guest nanoparticle for targeted therapy of inflammatory bowel disease.
    Zhang C; Zeng F; Fan Z; He Z; Tai L; Peng Q; Zhang Y; Chao Z; Jiang W; Jia L; Han L
    Acta Biomater; 2023 Oct; 169():422-433. PubMed ID: 37597682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOX4 promotes mucosal barrier injury in inflammatory bowel disease by mediating macrophages M1 polarization through ROS.
    Han C; Sheng Y; Wang J; Zhou X; Li W; Zhang C; Guo L; Yang Y
    Int Immunopharmacol; 2022 Mar; 104():108361. PubMed ID: 34949550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytically proficient ceria nanodots supported on redox-active mesoporous hosts for treatment of inflammatory bowel disease
    Wang H; Wang L; Chen Y; Huang J; Xing Y; Wang L; Zhang J; Yang H
    J Mater Chem B; 2023 Nov; 11(43):10369-10382. PubMed ID: 37873599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease.
    Chung CH; Jung W; Keum H; Kim TW; Jon S
    ACS Nano; 2020 Jun; 14(6):6887-6896. PubMed ID: 32449857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease.
    Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J
    Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc-Rutin Particles Ameliorate DSS-Induced Acute and Chronic Colitis via Anti-inflammatory and Antioxidant Protection of the Intestinal Epithelial Barrier.
    Wu W; Liu L; Zhu Y; Ni J; Lu J; Wang X; Ma L; Jiang Y
    J Agric Food Chem; 2023 Aug; 71(34):12715-12729. PubMed ID: 37581468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.
    Dijkstra G; Moshage H; van Dullemen HM; de Jager-Krikken A; Tiebosch AT; Kleibeuker JH; Jansen PL; van Goor H
    J Pathol; 1998 Dec; 186(4):416-21. PubMed ID: 10209492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered baicalein-decorated zinc phosphates for synergistic alleviation of inflammatory bowel disease by repairing the mucosal barrier and relieving oxidative stress.
    Liu L; Wu W; Li S; Ma L; Liu Y; Wang X; Jiang Y
    Biomater Sci; 2023 Nov; 11(23):7678-7691. PubMed ID: 37870399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair.
    Lei F; Zeng F; Yu X; Deng Y; Zhang Z; Xu M; Ding N; Tian J; Li C
    J Nanobiotechnology; 2023 Aug; 21(1):275. PubMed ID: 37596598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-targeting polyamine nanomedicines for the treatment of ulcerative colitis.
    Nishiguchi A; Taguchi T
    J Mater Chem B; 2023 May; 11(18):4005-4013. PubMed ID: 37039159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease.
    Zhao J; Gao W; Cai X; Xu J; Zou D; Li Z; Hu B; Zheng Y
    Theranostics; 2019; 9(10):2843-2855. PubMed ID: 31244927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.